Cargando…
Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
Physicians and patients have long been aware of skin lesions at the sites of insulin injections, referred to as lipodystrophy that can present as lipoatrophy (LA) or lipohypertrophy (LH). However, the reported prevalence of these different skin lesions varies widely, emphasizing the need for a corre...
Autores principales: | Gentile, Sandro, Strollo, Felice, Ceriello, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014793/ https://www.ncbi.nlm.nih.gov/pubmed/27456528 http://dx.doi.org/10.1007/s13300-016-0187-6 |
Ejemplares similares
-
Lipodistrophy and Associated Risk Factors in Insulin-Treated People With Diabetes
por: Gentile, Sandro, et al.
Publicado: (2016) -
COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
por: Gentile, Sandro, et al.
Publicado: (2020) -
The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak
por: Gentile, Sandro, et al.
Publicado: (2020) -
Local Lipodystrophy Following Insulin Injections
Publicado: (1930) -
A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes
por: Gentile, Sandro, et al.
Publicado: (2016)